Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Smilar Issues: 44 Record Found
Design and synthesis of some new heterocyclic benzylidene hydrazide derivatives for their antileishmanial activity
Pages 131-137 DOI : 10.12991/201317381
A facile in silico drug design strategy based on reference listed drugs and computational modeling of novel anticancer therapeutics
Pages 1067-1078 DOI : 10.35333/jrp.2019.71
Class I histone deacetylase inhibition by aryl butenoic acid derivatives: In silico and in vitro studies
Pages 952-959 DOI : 10.35333/jrp.2019.42
Novel nitrogen-containing heterocyclic compounds in GPR109A as an anti-hyperlipidemic: Homology modeling, docking, dynamic simulation studies
Pages 452-463 DOI : 10.35333/jrp.2020.193
Synthesis, in silico studies and cytotoxicity evaluation of novel 1,3,4-oxadiazole derivatives designed as potential mPGES-1 inhibitors
Pages 436-451 DOI : 10.35333/jrp.2020.187
Design, synthesis, antifungal activity, and QM/MM docking study of two azole derivatives with indole ring
Pages 681-692 DOI : 10.35333/jrp.2020.223
Molecular modeling and assessment of cytotoxic and apoptotic potentials of imatinib analogues featuring (thio)urea motifs in human leukemia and lymphoma cells
Pages 801-811 DOI : 10.35333/jrp.2020.239
Pyrrolо[1,2-a]azolo-(azino-)[c]quinazolines and their derivatives as 15-LOX inhibitors: Design, in vitro studies and QSAR-analysis
Pages 540-548 DOI : 10.29228/jrp.44
Bioflavonoids as potential target inhibitors in COVID-19: An in silico analysis
Pages 982-997 DOI : 10.29228/jrp.94
Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes
Pages 1010-1017 DOI : 10.29228/jrp.96
Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors – an in silico docking and ADMET simulation study
Pages 967-981 DOI : 10.29228/jrp.93
Molecular docking, molecular dynamic and drug-likeness studies of natural flavonoids as inhibitors for SARS-CoV-2 main protease (Mpro)
Pages 998-1009 DOI : 10.29228/jrp.95
Pyrazine-chromene-3-carbohydrazide conjugates: Molecular docking and ADMET predictions on dual-acting compounds against SARS-CoV-2 Mpro and RdRp
Pages 953-966 DOI : 10.29228/jrp.92
Role of nitrogen containing heterocyclic compounds in acyl Co-A carboxylase carboxyltransferase: Docking with dynamic simulation studies
Pages 035-043 DOI : 10.29228/jrp.101
Novel substituted oxadiazole - piperazine derivatives as potential MAO inhibitors: Design, synthesis, in vitro and in silico studies
Pages 020-027 DOI : 10.29228/jrp.99
A hybrid ligand and structure-based virtual screening of NCI compound library identifies potential SAPT1 inhibitors
Pages 617-624 DOI : 10.29228/jrp.159
Investigation of Atorvastatin interaction with human serum albumin: evaluation of pH effect and competitive binding with warfarin
Pages 1386-1402 DOI : 10.29228/jrp.232
Benzofuran fused phenyl pyrimidine/pyrazole schiff base derivatives as bioactive agents: anticancer, antimicrobial and molecular docking studies
Pages 1432-1442 DOI : 10.29228/jrp.236
Inhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme
Pages 1461-1471 DOI : 10.29228/jrp.239
QSAR and Molecular Docking of Pyrimidine Derivatives Against Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS)
Pages 1723-1735 DOI : 10.29228/jrp.284
Euphorbia neriifolia L. phytochemical lead compounds discovered using pharmacoinformatic methods as possible SARS CoV-2 main protease inhibitors
Pages 157-172 DOI : 10.29228/jrp.300
Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents
Pages 207-220 DOI : 10.29228/jrp.304
Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus
Pages 221-231 DOI : 10.29228/jrp.305
In silico evaluation of potential murine M49 DNA aptamer on ORF7a of SARS-COV-2: A similar target
Pages 232-240 DOI : 10.29228/jrp.306
In vitro, in silico and in vivo screening of non-oncology drugs for repurposing in osteosarcoma
Pages 712-721 DOI : 10.29228/jrp.354
Pharmacophore-based Molecular Docking of Usnic Acid Derivatives to Discover Anti-viral drugs Against Influenza A Virus
Pages 1021-1038 DOI : 10.29228/jrp.396
Synthesis, In Silico and Structural Insight of Flavonol Derivative Compounds as New Competitive Dengue NS2B/NS3 Protease Inhibitor
Pages 1157-1169 DOI : 10.29228/jrp.406
Pharmacophore-based Virtual Screening: Identification of Selective Sirtuin 2 Inhibitors
Pages 1366-1379 DOI : 10.29228/jrp.424
Fingerprint-based QSAR Model Generation to Identify Structural Determinants of HCV NS5B Inhibition
Pages 1421-1430 DOI : 10.29228/jrp.429
The protective effect of grape seed extract (Vitis vinifera) against mesenteric ischemia/reperfusion injury in rats: an in vivo, in vitro and molecular docking study
Pages 1513-1523 DOI : 10.29228/jrp.437
In silico modeling of α-glucosidase, aldose reductase, and PPAR-γ with benzoyl/sulfonyl hydrazone derivatives using molecular docking, ADMET, and molecular dynamics simulations
Pages 1567- 1576 DOI : 10.29228/jrp.442
COMPUTATIONAL IDENTIFICATION OF NOVEL TARGETS FOR DRUG CANDIDATE COMPOUNDS
Pages 009-012 DOI : 10.29228/jrp.455
DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
Pages 013-015 DOI : 10.29228/jrp.456
Molecular docking and drug-likeness study of nirmatrelvir as promising drug candidates of dengue virus NS2B-NS3 protease
Pages 1760-1767 DOI : 10.29228/jrp.460
Exploring the anticancer activity and active mechanism of turkish propolis against hl-60 myeloid cancer cells: insights from molecular docking studies
Pages 2163-2170 DOI : 10.29228/jrp.495
Molecular Modelling of Some Ligands Against Acetylcholinesterase to Treat Alzheimer’s Disease
Pages 2199-2209 DOI : 10.29228/jrp.510
Molecular docking approach to identify xanthine oxidase inhibitory effect of bioactive compounds in Pogostemon cablin (Blanco) Benth
Pages 2452-2462 DOI : 10.29228/jrp.532
OP21. IN VITRO AND IN SILICO EVALUATION OF THE ANTIVIRAL POTENTIAL OF EUCALYPTUS ESSENTIAL OILS
Pages 21
In vitro and in silico cytotoxicity effects of Zanthoxylum simulans Hance. fruit bark extract against gastric cancer cell lines
Pages 110-125 DOI : 10.29228/jrp.680
Antiviral Properties of 5‑Sulfamoyl‑1H‑Indole-Linked Spirothiazolidinone Derivatives: A Study on Human Parainfluenza Virus-2
Pages 213-224 DOI : 10.29228/jrp.689
Biophysical and thermodynamical insights into the interaction of mefenamic acid with human serum albumin, based on combined multi-spectroscopic and molecular modeling approaches
Pages 372-384 DOI : 10.29228/jrp.703
Effects of lesinurad on HEK-293 human kidney cells: In vitro and molecular docking evaluation
Pages 708-721 DOI : 10.29228/jrp.733
Inhibition of pancreatic cancer via LPAR4 receptor with a de novo drug complex design using theoretical organic chemistry: Comprehensive molecular docking, molecular dynamics
Pages 1033-1040 DOI : 10.29228/jrp.785
Colchicine as a potential HDAC inhibitor: comparative binding energies and prospects for cancer therapy repurposing
Pages 1812-1819 DOI : 10.29228/jrp.853
Pages 131-137 DOI : 10.12991/201317381
A facile in silico drug design strategy based on reference listed drugs and computational modeling of novel anticancer therapeutics
Pages 1067-1078 DOI : 10.35333/jrp.2019.71
Class I histone deacetylase inhibition by aryl butenoic acid derivatives: In silico and in vitro studies
Pages 952-959 DOI : 10.35333/jrp.2019.42
Novel nitrogen-containing heterocyclic compounds in GPR109A as an anti-hyperlipidemic: Homology modeling, docking, dynamic simulation studies
Pages 452-463 DOI : 10.35333/jrp.2020.193
Synthesis, in silico studies and cytotoxicity evaluation of novel 1,3,4-oxadiazole derivatives designed as potential mPGES-1 inhibitors
Pages 436-451 DOI : 10.35333/jrp.2020.187
Design, synthesis, antifungal activity, and QM/MM docking study of two azole derivatives with indole ring
Pages 681-692 DOI : 10.35333/jrp.2020.223
Molecular modeling and assessment of cytotoxic and apoptotic potentials of imatinib analogues featuring (thio)urea motifs in human leukemia and lymphoma cells
Pages 801-811 DOI : 10.35333/jrp.2020.239
Pyrrolо[1,2-a]azolo-(azino-)[c]quinazolines and their derivatives as 15-LOX inhibitors: Design, in vitro studies and QSAR-analysis
Pages 540-548 DOI : 10.29228/jrp.44
Bioflavonoids as potential target inhibitors in COVID-19: An in silico analysis
Pages 982-997 DOI : 10.29228/jrp.94
Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes
Pages 1010-1017 DOI : 10.29228/jrp.96
Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors – an in silico docking and ADMET simulation study
Pages 967-981 DOI : 10.29228/jrp.93
Molecular docking, molecular dynamic and drug-likeness studies of natural flavonoids as inhibitors for SARS-CoV-2 main protease (Mpro)
Pages 998-1009 DOI : 10.29228/jrp.95
Pyrazine-chromene-3-carbohydrazide conjugates: Molecular docking and ADMET predictions on dual-acting compounds against SARS-CoV-2 Mpro and RdRp
Pages 953-966 DOI : 10.29228/jrp.92
Role of nitrogen containing heterocyclic compounds in acyl Co-A carboxylase carboxyltransferase: Docking with dynamic simulation studies
Pages 035-043 DOI : 10.29228/jrp.101
Novel substituted oxadiazole - piperazine derivatives as potential MAO inhibitors: Design, synthesis, in vitro and in silico studies
Pages 020-027 DOI : 10.29228/jrp.99
A hybrid ligand and structure-based virtual screening of NCI compound library identifies potential SAPT1 inhibitors
Pages 617-624 DOI : 10.29228/jrp.159
Investigation of Atorvastatin interaction with human serum albumin: evaluation of pH effect and competitive binding with warfarin
Pages 1386-1402 DOI : 10.29228/jrp.232
Benzofuran fused phenyl pyrimidine/pyrazole schiff base derivatives as bioactive agents: anticancer, antimicrobial and molecular docking studies
Pages 1432-1442 DOI : 10.29228/jrp.236
Inhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme
Pages 1461-1471 DOI : 10.29228/jrp.239
QSAR and Molecular Docking of Pyrimidine Derivatives Against Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS)
Pages 1723-1735 DOI : 10.29228/jrp.284
Euphorbia neriifolia L. phytochemical lead compounds discovered using pharmacoinformatic methods as possible SARS CoV-2 main protease inhibitors
Pages 157-172 DOI : 10.29228/jrp.300
Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents
Pages 207-220 DOI : 10.29228/jrp.304
Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus
Pages 221-231 DOI : 10.29228/jrp.305
In silico evaluation of potential murine M49 DNA aptamer on ORF7a of SARS-COV-2: A similar target
Pages 232-240 DOI : 10.29228/jrp.306
In vitro, in silico and in vivo screening of non-oncology drugs for repurposing in osteosarcoma
Pages 712-721 DOI : 10.29228/jrp.354
Pharmacophore-based Molecular Docking of Usnic Acid Derivatives to Discover Anti-viral drugs Against Influenza A Virus
Pages 1021-1038 DOI : 10.29228/jrp.396
Synthesis, In Silico and Structural Insight of Flavonol Derivative Compounds as New Competitive Dengue NS2B/NS3 Protease Inhibitor
Pages 1157-1169 DOI : 10.29228/jrp.406
Pharmacophore-based Virtual Screening: Identification of Selective Sirtuin 2 Inhibitors
Pages 1366-1379 DOI : 10.29228/jrp.424
Fingerprint-based QSAR Model Generation to Identify Structural Determinants of HCV NS5B Inhibition
Pages 1421-1430 DOI : 10.29228/jrp.429
The protective effect of grape seed extract (Vitis vinifera) against mesenteric ischemia/reperfusion injury in rats: an in vivo, in vitro and molecular docking study
Pages 1513-1523 DOI : 10.29228/jrp.437
In silico modeling of α-glucosidase, aldose reductase, and PPAR-γ with benzoyl/sulfonyl hydrazone derivatives using molecular docking, ADMET, and molecular dynamics simulations
Pages 1567- 1576 DOI : 10.29228/jrp.442
COMPUTATIONAL IDENTIFICATION OF NOVEL TARGETS FOR DRUG CANDIDATE COMPOUNDS
Pages 009-012 DOI : 10.29228/jrp.455
DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
Pages 013-015 DOI : 10.29228/jrp.456
Molecular docking and drug-likeness study of nirmatrelvir as promising drug candidates of dengue virus NS2B-NS3 protease
Pages 1760-1767 DOI : 10.29228/jrp.460
Exploring the anticancer activity and active mechanism of turkish propolis against hl-60 myeloid cancer cells: insights from molecular docking studies
Pages 2163-2170 DOI : 10.29228/jrp.495
Molecular Modelling of Some Ligands Against Acetylcholinesterase to Treat Alzheimer’s Disease
Pages 2199-2209 DOI : 10.29228/jrp.510
Molecular docking approach to identify xanthine oxidase inhibitory effect of bioactive compounds in Pogostemon cablin (Blanco) Benth
Pages 2452-2462 DOI : 10.29228/jrp.532
OP21. IN VITRO AND IN SILICO EVALUATION OF THE ANTIVIRAL POTENTIAL OF EUCALYPTUS ESSENTIAL OILS
Pages 21
In vitro and in silico cytotoxicity effects of Zanthoxylum simulans Hance. fruit bark extract against gastric cancer cell lines
Pages 110-125 DOI : 10.29228/jrp.680
Antiviral Properties of 5‑Sulfamoyl‑1H‑Indole-Linked Spirothiazolidinone Derivatives: A Study on Human Parainfluenza Virus-2
Pages 213-224 DOI : 10.29228/jrp.689
Biophysical and thermodynamical insights into the interaction of mefenamic acid with human serum albumin, based on combined multi-spectroscopic and molecular modeling approaches
Pages 372-384 DOI : 10.29228/jrp.703
Effects of lesinurad on HEK-293 human kidney cells: In vitro and molecular docking evaluation
Pages 708-721 DOI : 10.29228/jrp.733
Inhibition of pancreatic cancer via LPAR4 receptor with a de novo drug complex design using theoretical organic chemistry: Comprehensive molecular docking, molecular dynamics
Pages 1033-1040 DOI : 10.29228/jrp.785
Colchicine as a potential HDAC inhibitor: comparative binding energies and prospects for cancer therapy repurposing
Pages 1812-1819 DOI : 10.29228/jrp.853